Association between the G1001C polymorphism in the GRIN1 gene promoter and schizophrenia in the Iranian population.
Schizophrenia is a complex genetic disorder to which genetic variation in the glutamatergic signaling pathways is believed to play a substantial role in the etiology of the disease. Association studies have implicated the N-methyl-D-aspartate receptor subunit gene, GRIN1, as a candidate gene for schizophrenia. In this report, we used a case control study to establish the possible association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia in an Iranian cohort of 200 unrelated patients and 200 controls. The allelic and genotypic frequencies of the polymorphism were determined using polymerase chain reaction restriction fragment length polymorphism. Data analysis using logistic regression and the Mantel-Haenszel chi-square test revealed a strong association between the G1001C polymorphism and schizophrenia (CG genotype: odds ratio (OR) = 2.12, 95% confidence interval (CI) 1.34-3.48, P = 0.001 and CC genotype: OR = 29.10, 95% CI 3.40-565.78, P < 0.001). Furthermore, the C allele is significantly associated with an increasing risk of schizophrenia.
Galehdari
Hamid
H
Shahid Chamran University, Ahvaz, Iran. galehdari@scu.ac.ir
Pooryasin
Atefeh
A
Foroughmand
Alimohammad
A
Daneshmand
Setareh
S
Saadat
Mostafa
M
D000328:Adult; D002352:Carrier Proteins / Q000235:genetics*; D016022:Case-Control Studies; D005006:Ethnicity / Q000235:genetics; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D007492:Iran; D008875:Middle Aged; D009419:Nerve Tissue Proteins / Q000235:genetics*; D011110:Polymorphism, Genetic; D011401:Promoter Regions, Genetic; D016194:Receptors, N-Methyl-D-Aspartate / Q000235:genetics*; D012559:Schizophrenia / Q000235:genetics* / Q000503:physiopathology; D017422:Sequence Analysis, DNA
D002352:Carrier Proteins; C485668:GRIN1 protein, human; D009419:Nerve Tissue Proteins; D016194:Receptors, N-Methyl-D-Aspartate
Biol Psychiatry. 2006 Apr 15;59(8):747-53
16476413
Am J Med Genet B Neuropsychiatr Genet. 2003 May 15;119B(1):24-7
12707933
Biol Psychiatry. 2003 Apr 1;53(7):617-9
12679240
Cell. 1999 Aug 20;98(4):427-36
10481908
Arch Gen Psychiatry. 2005 Nov;62(11):1196-204
16275807
Curr Psychiatry Rep. 2003 Jun;5(2):121-7
12685991
Am J Psychiatry. 1991 Oct;148(10):1301-8
1654746
Annu Rev Neurosci. 1993;16:207-22
8460891
Am J Psychiatry. 2001 Sep;158(9):1367-77
11532718
Psychiatr Genet. 2007 Oct;17(5):308-10
17728671
Annu Rev Neurosci. 1994;17:31-108
8210177
Schizophr Bull. 2008 Sep;34(5):806-12
18644854
Mol Psychiatry. 2002;7(5):508-14
12082569
Psychiatr Genet. 2002 Dec;12(4):225-30
12454527
Eur Arch Psychiatry Clin Neurosci. 2000;250(6):274-85
11153962
Neurosignals. 2004 Jul-Aug;13(4):194-206
15148448
Schizophr Res. 2002 Nov 1;58(1):83-6
12363394
Am J Med Genet. 1998 Jul 10;81(4):290-5
9674973
Neurosci Lett. 2000 Dec 22;296(2-3):168-70
11109007
Mol Psychiatry. 2001 May;6(3):274-84
11326295
Science. 1992 May 22;256(5060):1217-21
1350383
Nat Genet. 2008 Jul;40(7):827-34
18583979
Behav Brain Res. 2008 Jan 10;186(1):78-83
17854919
Mol Psychiatry. 2005 Jan;10(1):40-68; image 5
15263907
Schizophr Bull. 2007 Jan;33(1):95-104
17035359
Eur J Hum Genet. 2005 Jul;13(7):807-14
15841096
Brain Res Brain Res Rev. 2000 Mar;31(2-3):288-94
10719155
Schizophr Res. 2004 Jul 1;69(1):67-73
15145472